Encompass Health Co. (NYSE:EHC) Receives $107.11 Average Price Target from Analysts

Encompass Health Co. (NYSE:EHC) has received a consensus rating of “Buy” from the eleven brokerages that are currently covering the firm, Marketbeat Ratings reports. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $107.11.

A number of equities analysts have weighed in on the stock. Barclays upped their price objective on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. KeyCorp raised their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research note on Tuesday, October 29th. Royal Bank of Canada increased their target price on Encompass Health from $105.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, October 30th. Finally, Truist Financial reaffirmed a “buy” rating and issued a $116.00 price target (up from $108.00) on shares of Encompass Health in a research note on Wednesday, October 30th.

Encompass Health Trading Up 0.6 %

Shares of EHC stock opened at $98.99 on Friday. Encompass Health has a 1-year low of $70.83 and a 1-year high of $104.55. The company has a market cap of $9.97 billion, a price-to-earnings ratio of 23.91, a PEG ratio of 1.14 and a beta of 0.89. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a 50 day simple moving average of $96.52 and a 200-day simple moving average of $94.70.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. MassMutual Private Wealth & Trust FSB grew its holdings in shares of Encompass Health by 87.8% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock valued at $27,000 after purchasing an additional 137 shares during the period. UMB Bank n.a. grew its stake in shares of Encompass Health by 387.7% in the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company’s stock valued at $31,000 after buying an additional 252 shares during the period. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new position in Encompass Health in the third quarter valued at approximately $40,000. Finally, Benjamin F. Edwards & Company Inc. grew its position in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock worth $46,000 after acquiring an additional 198 shares during the period. Hedge funds and other institutional investors own 97.25% of the company’s stock.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.